Peter Gerhardsson
Directeur/Membre du Conseil chez GlucoModicum Oy
Profil
Peter Gerhardsson is currently the Director at GlucoModicum Oy and also holds a Director position at AMF Medical SA. Previously, he worked as the Business Director-European Diabetes Division at Medtronic, Inc. and as the Vice President-Corporate Social Responsibility at Novo Nordisk A.
He also served as the Vice President-International Business Development at DexCom, Inc. Mr. Gerhardsson holds an MBA from Stanford University and undergraduate degrees from the University of Linköping and the University of Lund.
Postes actifs de Peter Gerhardsson
| Sociétés | Poste | Début |
|---|---|---|
GlucoModicum Oy
 GlucoModicum Oy Electronic Equipment/InstrumentsElectronic Technology GlucoModicum Oy is a company based in Helsinki, FI that is transforming glucose monitoring with precise, needle-free magnetohydrodynamic technology. GlucoModicum was founded in 2018 as a spinout of the University of Helsinki and combines an experienced, multi-disciplinary in-house team with world-class partners to deliver groundbreaking solutions for personal biomarker monitoring. The Finnish company's proprietary platform has the potential to radically change how people monitor their health, creating solutions that are precise, accessible, and needle-free, empowering people to live healthier lives. The company's first product is a non-invasive, wearable glucose monitor for patients suffering from diabetes. The company was founded in 2018 by Johan Bobacka. The CEO is Jokke Mäki. | Directeur/Membre du Conseil | 07/09/2022 |
AMF Medical SA
 AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter Gerhardsson
| Sociétés | Poste | Fin |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/05/2008 |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | 01/05/2008 |
| DEXCOM, INC. | Corporate Officer/Principal | - |
Formation de Peter Gerhardsson
| Stanford University | Masters Business Admin |
| University of Linköping | Undergraduate Degree |
| University of Lund | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| DEXCOM, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
GlucoModicum Oy
GlucoModicum Oy Electronic Equipment/InstrumentsElectronic Technology GlucoModicum Oy is a company based in Helsinki, FI that is transforming glucose monitoring with precise, needle-free magnetohydrodynamic technology. GlucoModicum was founded in 2018 as a spinout of the University of Helsinki and combines an experienced, multi-disciplinary in-house team with world-class partners to deliver groundbreaking solutions for personal biomarker monitoring. The Finnish company's proprietary platform has the potential to radically change how people monitor their health, creating solutions that are precise, accessible, and needle-free, empowering people to live healthier lives. The company's first product is a non-invasive, wearable glucose monitor for patients suffering from diabetes. The company was founded in 2018 by Johan Bobacka. The CEO is Jokke Mäki. | Electronic Technology |
AMF Medical SA
AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | Electronic Technology |